Anlon Healthcare IPO Day 2: Check GMP, Subscription Status & Key Highlights
Today is Day 2 of the Anlon Healthcare IPO, which opened on 26 August 2025. On day 1, the IPO received a muted response and a total subscription of 1.69 times. The bidding window is scheduled to close on Aug 29, 2025.
Anlon Healthcare IPO: Issue Details
Anlon Healthcare IPO is a book-building issue of ₹121.03 crores, consisting entirely of a fresh issue of 1.33 crore shares. The price band is set between ₹86 and ₹91 per share. The basis of allotment will be finalised by September 1, 2025, and the tentative listing date on NSE and BSE is September 3, 2025.
The book running lead manager for the IPO is Interactive Financial Services Limited, while MUFG Intime India Private Limited (Link Intime) is the registrar for the issue.
Anlon Healthcare IPO Day 2 Subscription Status
[28-August-2025 11:18:00 AM]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.91 |
|
Non-Institutional Investors |
1.28 |
|
Retail Individual Investors (RIIs) |
14.92 |
|
Total |
2.37 |
Anlon Healthcare IPO Day 1 Subscription Status
[26-August-2025 17:00:00]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.91 |
|
Non-Institutional Investors |
0.71 |
|
Retail Individual Investors (RIIs) |
8.98 |
|
Total |
1.69 |
Read More: Anlon Healthcare IPO Day 1 Subscription Status
Utilisation of IPO Proceeds
The company will not receive any proceeds from the OFS component and will directly go to the selling shareholders.
The net proceeds from the fresh issue will be used to fund the following objectives:
- Expansion of the manufacturing facility
- Working capital requirements
- Repayment/prepayment of the company’s outstanding borrowings
- General corporate purposes
Check out newly Listed IPOs on BSE and NSE.
Anlon Healthcare IPO GMP Details
As of 28 August 2025, Anlon Healthcare's IPO's GMP stood at ₹5. The estimated listing price is ₹96, i.e., a 5.49% gain per share over the upper price band.
|
Source: Business Standard Report dated 28 August, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Explore other Upcoming IPOs on BSE and NSE.
Anlon Healthcare Business Overview
Anlon Healthcare is a chemical manufacturing company and is engaged in the business of manufacturing advanced pharmaceutical intermediates and active pharmaceutical ingredients. Their product portfolio encompasses the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and personal care and veterinary API ingredients.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.